TYMS and cancer: To test this hypothesis, we performed genotyping analyses for TS 5'-UTR TSER and TS 3'-UTR del6 polymorphisms in a case-control study of 432 incident cases with invasive breast cancer and 473 cancer-free controls in a Chinese population.